rheumatoidarthritisnews.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: */xmlrpc.php Disallow: */wp-*.php Disallow: */trackback/ Disallow: *?wptheme= Disallow: *?comments= Disallow: *?replytocom Disallow: */comment-page- Disallow: *?s= Disallow: /feed/ Disallow: /tag/* Disallow: /readme.html Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Rheumatoid Arthritis News - Rheumatoid Arthritis |
| Description | Home Treatments Tofacitinib (Xeljanz) Experimental Treatments Piclidenoson Kevzara (Sarilumab) Baricitinib (Olumiant) About Us Contact Us Search for: June |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.170.189 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
rheumatoidarthritisnews.com Valuation
|
US$1,037,370
Last updated: 2023-05-13 04:10:24
rheumatoidarthritisnews.com has Semrush global rank of 10,203,018. rheumatoidarthritisnews.com has an estimated worth of US$ 1,037,370, based on its estimated Ads revenue. rheumatoidarthritisnews.com receives approximately 119,697 unique visitors each day. Its web server is located in United States, with IP address 172.67.170.189. According to SiteAdvisor, rheumatoidarthritisnews.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,037,370 |
| Daily Ads Revenue | US$958 |
| Monthly Ads Revenue | US$28,728 |
| Yearly Ads Revenue | US$344,726 |
| Daily Unique Visitors | 7,980 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| rheumatoidarthritisnews.com. 300 IN | A | IP: 172.67.170.189 | |
| rheumatoidarthritisnews.com. 300 IN | A | IP: 104.21.55.75 | |
| rheumatoidarthritisnews.com. 300 IN | AAAA | IPV6: 2606:4700:3032::ac43:aabd | |
| rheumatoidarthritisnews.com. 300 IN | AAAA | IPV6: 2606:4700:3037::6815:374b | |
| rheumatoidarthritisnews.com. 86400 IN | NS | NS Record: aiden.ns.cloudflare.com. | |
| rheumatoidarthritisnews.com. 86400 IN | NS | NS Record: jasmine.ns.cloudflare.com. | |
| rheumatoidarthritisnews.com. 300 IN | MX | MX Record: 0 mail.rheumatoidarthritisnews.com. | |
| rheumatoidarthritisnews.com. 300 IN | TXT | TXT Record: v=spf1 a mx ptr include:bluehost.com ?all |
HtmlToTextCheckTime:2023-05-13 04:10:24
| Home Treatments Tofacitinib (Xeljanz) Experimental Treatments Piclidenoson Kevzara (Sarilumab) Baricitinib (Olumiant) About Us Contact Us Search for: June 12, 2017 August 24, 2022 Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more June 7, 2017 June 7, 2017 Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more June 5, 2017 June 5, 2017 EMA Accepts Humira and Remicade Biosimilars for Regulatory Review The European Medicines Agency (EMA) has accepted a marketing authorization application from generic |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Mon, 20 Dec 2021 16:26:51 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Mon, 20 Dec 2021 17:26:51 GMT
Location: https://rheumatoidarthritisnews.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=JVZ7gocYe6sq1TvPQXW08%2Bh914mnP%2Fb2kgLDYjYe3fYo810U7zw5jpPbshsUE62y%2FVnh%2BZbEOAuFlNZGrU7epu5clSoYD0b9O5gu091CZlQK%2FbRs7ZC4fJYfqbDbddVCyN0JkbhyW1rZJbOUjZE%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6c0a3c15ee8757d2-IAD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Mon, 20 Dec 2021 16:26:51 GMT
content-type: text/html
last-modified: Mon, 20 Dec 2021 03:27:22 GMT
vary: Accept-Encoding
cache-control: no-store, no-cache, must-revalidate
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=QXGPXG%2BCkxuOQAd82y5ZFV3IkpWliSrAnVW4gvFHktIDozxr2Bvy1RwEG6SI8Vh%2BloRKTv4sBAS7O%2FYvacDaj3M%2BgKfIIa%2BtZUwX15d0S8fDTKSfzM7J1X8LOjSAp8qT3WdqZZAfI9f636tj03s%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c0a3c166e26cecc-IAD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
rheumatoidarthritisnews.com Whois Information
Domain Name: RHEUMATOIDARTHRITISNEWS.COM Registry Domain ID: 1888505157_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-11-19T15:37:38Z Creation Date: 2014-12-03T18:44:18Z Registry Expiry Date: 2022-12-03T18:44:18Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: AIDEN.NS.CLOUDFLARE.COM Name Server: JASMINE.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:37:52Z <<< |